Trial Profile
A Phase III Randomized, Double-blind, Dose-Controlled, Multicenter, Study Evaluating the Safety and Efficacy of Dexmedetomidine in Intubated and Mechanically Ventilated Pediatric Intensive Care Unit Subjects
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary) ; Fentanyl; Midazolam; Morphine
- Indications Sedation
- Focus Registrational; Therapeutic Use
- Sponsors Hospira
- 30 Mar 2014 New trial record